Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
2,54 USD | -1,17% | +2,01% | -15,05% |
30/04 | Transcript : Nautilus Biotechnology, Inc., Q1 2024 Earnings Call, Apr 30, 2024 | |
28/02 | Transcript : Nautilus Biotechnology, Inc., Q4 2023 Earnings Call, Feb 28, 2024 |
Attività
Numero di dipendenti: 167
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Parag Mallick
FOU | Founder | 47 | 01/01/16 |
Sujal Patel
FOU | Founder | 49 | 01/01/16 |
Anna Mowry
DFI | Director of Finance/CFO | 46 | 09/06/21 |
Mary Godwin
COO | Chief Operating Officer | 65 | 01/01/20 |
Public Communications Contact | - | 01/01/21 | |
Nick Nelson
PRN | Corporate Officer/Principal | 41 | 09/06/21 |
Martin Huber
PRN | Corporate Officer/Principal | - | 01/11 |
Subra Sankar
PRN | Corporate Officer/Principal | 64 | 01/12/20 |
Matthew Murphy
LAW | General Counsel | 59 | 09/06/21 |
Gwen Weld
HRO | Human Resources Officer | 66 | 12/04/22 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Matthew Posard
CHM | Chairman | 56 | 01/01/19 |
Farzad Nazem
BRD | Director/Board Member | 62 | 09/06/21 |
Matt McIlwain
BRD | Director/Board Member | 59 | 09/06/21 |
Sujal Patel
FOU | Founder | 49 | 01/01/16 |
Michael Altman
BRD | Director/Board Member | 42 | 09/06/21 |
Melissa Epperly
BRD | Director/Board Member | 46 | 09/06/21 |
Vijay Pande
BRD | Director/Board Member | 53 | 09/06/21 |
Parag Mallick
FOU | Founder | 47 | 01/01/16 |
Karen Akinsanya
BRD | Director/Board Member | 56 | 30/03/22 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 125 265 015 | 70 209 342 ( 56,05 %) | 0 | 56,05 % |
Coordinate società
Settore
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
-15,05% | 322 Mln | |
+0,17% | 42,86 Mrd | |
+10,92% | 42,74 Mrd | |
+44,30% | 41,36 Mrd | |
-6,20% | 27,68 Mrd | |
+5,23% | 25,15 Mrd | |
-24,79% | 18,63 Mrd | |
+26,69% | 12,37 Mrd | |
-3,13% | 11,92 Mrd | |
+6,57% | 11,21 Mrd |
- Borsa valori
- Azioni
- Azione NAUT
- Società Nautilus Biotechnology, Inc.